EURO Pharma Ltd.

What EURO Pharma Ltd. does

EURO Pharma Ltd. is a Bangladesh-based, privately held generic pharmaceutical manufacturer incorporated in 2003. It received regulatory approval in July 2006 to manufacture and market medicines in Bangladesh and commenced commercial production and marketing in March 2008. The company operates a single manufacturing facility at 385 West Jurain, Shaympur Industrial Area, Dhaka-1204, alongside its head office at Rose View Plaza (11th Floor), 185 Bir Uttam C. R. Datta Road, Hatirpool, Dhaka-1205, and is led by a Board of Directors chaired by Professor S.M. Ashiquzzaman with Professor Borhan Uddin Khan as Managing Director.

The company's core offering is a portfolio of approximately 100+ branded generic pharmaceutical products spanning 35+ therapeutic categories, including analgesics and antipyretics, antibiotics (oral and injectable cephalosporins, macrolides, fluoroquinolones, carbapenems), antihypertensives (ARB and ARB+diuretic combinations), antidiabetics (including newer SGLT2 and DPP-4 agents), antiulcerants, dermatologicals, antifungals, antihistamines, antipsychotics, and multivitamin/multimineral preparations. Dosage forms include tablets, capsules, syrups, injections, creams, ointments, and sachets, plus consumer products such as hand sanitizers and oral saline. Manufacturing and formulation technology emphasizes zero-defect quality control embedded at every stage from procurement through delivery and disposal.

EURO Pharma operates an enterprise field sales GTM model targeting healthcare providers, pharmacies, and patients in Bangladesh, supported by a nationwide distribution network of 24 regional depots covering every major administrative division of the country. Revenue is generated through one-time sales of pharmaceutical products at price points typical of the regulated Bangladesh generics market (pricing is not publicly disclosed). Marketing is executed through a medical representative field force for bottom-of-funnel physician engagement and a corporate website for top-of-funnel product information. The company employs approximately 141 staff and serves a horizontal segment of healthcare providers and patients across Bangladesh, with no disclosed export footprint, partnerships, or institutional customers.

Name

EURO Pharma Ltd.

Legal name

Euro Pharma Ltd.

Website

https://europharmabd.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

EURO Pharma Ltd. is a Bangladesh-based generic pharmaceutical manufacturer founded in 2003, producing approximately 100+ branded generic medicines across 35+ therapeutic categories and distributing them nationwide through 24 regional depots serving healthcare providers, pharmacies, and patients.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Generic pharmaceutical manufacturing
• Branded generics Bangladesh
• Pharmaceutical distribution network
• Therapeutic formulations
• Oral solid dosage forms

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices26 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and marketing generic pharmaceutical products across Bangladesh. The company produces a broad portfolio of products including tablets, capsules, syrups, injections, creams, and ointments across multiple therapeutic categories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

EURO Pharma Ltd. manufactures and markets a broad portfolio of branded generic pharmaceutical products in Bangladesh. Its portfolio spans multiple therapeutic categories — analgesics and antipyretics, antibiotics, antidiabetics, antihypertensives, antifungals, gastrointestinal, cardiovascular, respiratory, dermatological, and multivitamins — delivered as tablets, capsules, syrups, injections, creams, and ointments. The company operates an in-house manufacturing facility in Dhaka and distributes nationwide through 24 regional depots to healthcare providers, pharmacies, and hospitals.

Product overview

EURO Pharma Ltd. is a pharmaceutical company in Bangladesh incorporated in 2003, operating as a manufacturer and marketer of generic medicines. The company's product portfolio is a broad portfolio of generic pharmaceutical products organized by therapeutic class, including Analgesic & Antipyretic, Antibiotic, Antidiabetic, Antihypertensive, Antifungal, Gastrointestinal, Cardiovascular, Respiratory, Dermatological, and Multivitamin products. Key products include Olmetor (Olmesartan Medoxomil), Rosufast (Rosuvastatin), Prosulin (Tamsulosin), AmbroKof (Ambroxol), various antibiotics (Adiz, Ceficap, Cetaxone), gastrointestinal products (Gap, Protozin), and consumer products (hand sanitizers, oral saline). The company focuses on high-quality generic formulations and maintains an extensive distribution network across Bangladesh through 24 regional depots. The product portfolio encompasses approximately 100+ branded generic pharmaceutical products spanning multiple therapeutic categories.

Differentiator

Problem solved

Functional benefit

Products and services

• Olmetor Tablet containing Olmesartan Medoxomil USP, used for treatment of hypertension. Available in 10 mg, 20 mg, and 40 mg strengths.
• Olmetor AM Tablet containing Amlodipine Besilate BP and Olmesartan Medoxomil USP, indicated for treatment of hypertension alone or with other antihypertensive agents.
• Olmetor Plus Tablet containing Olmesartan Medoxomil USP and Hydrochlorothiazide USP, indicated for the treatment of hypertension. Available in 20 mg and 40 mg strengths.
• Rosufast Tablet containing Rosuvastatin Calcium BP, indicated for hyperlipidaemias, primary hypercholesterolaemia, mixed dyslipidaemia, and stroke prevention.
• AmbroKof Syrup containing Ambroxol Hydrochloride BP 15 mg per 5 ml, used for acute and chronic diseases of respiratory tracts associated with viscid mucus including bronchitis, productive cough, and asthmatic bronchitis.
• Prosulin Capsule containing Tamsulosin Hydrochloride Sustained Release Pellets, indicated for benign prostatic hyperplasia.
• Prosulin-D Capsule containing Tamsulosin Hydrochloride Sustained Release Pellets and Dutasteride, indicated for benign prostatic hyperplasia.
• Lopoten Plus Tablet containing Losartan Potassium BP and Hydrochlorothiazide USP, indicated for hypertension, stroke, and risk reduction of hypertensive or LVH patients.
• Lopoten Tablet containing Losartan potassium INN, indicated for hypertension and diabetic nephropathy in type 2 diabetes mellitus.
• Ezyfeel Tablet and oral solution containing Sodium Picosulfate BP, indicated for constipation, bowel clearance before surgery, childbirth or radiological investigations.
• Adiz Tablet containing Azithromycin Dihydrate USP, indicated for respiratory tract infections, otitis media, skin and soft tissue infections, typhoid, cholera and sexually transmitted diseases.
• Alterin Enteric coated tablet containing Diclofenac Sodium BP 50 mg, used for inflammatory and degenerative forms of rheumatism, osteoarthritis, and pain management.
• Alterin TR Capsule containing timed release Diclofenac Sodium pellets, used for relief of pain and inflammation in arthritic conditions and acute musculoskeletal disorders.
• Amtinol Tablet containing Amlodipine besilate BP, indicated for treatment of hypertension and angina.
• Amtinol Plus Tablet containing Amlodipine besilate BP and Atenolol BP, indicated for hypertension, chronic stable angina, post MI patients, and refractory angina.
• Anolol Tablet containing Atenolol BP, indicated for hypertension, angina pectoris, cardiac arrhythmia, and myocardial infarction.
• Antage Film coated tablet containing Vitamin C BP 200mg and Vitamin E BP 200 mg, indicated for reduced risks of cardiovascular diseases and cataract.
• Aster EZ Tablet containing Atorvastatin Calcium Trihydrate USP and Ezetimibe USP, indicated for reduction of elevated cholesterol levels in primary hyperlipidemia and homozygous familial hypercholesterolemia.
• Axepime IV injection containing Cefepime 1 gm, indicated for skin and skin structure infections, urinary tract infection, nosocomial pneumonia.
• Azmarel Tablet and syrup containing Salbutamol Sulphate BP, indicated as bronchodilator for asthma, chronic bronchitis, and emphysema.
• Bisopol Tablet containing Bisoprolol Fumarate USP, indicated for hypertension, angina pectoris, and congestive heart failure.
• Bisopol-A Tablet containing Bisoprolol Fumarate USP and Amlodipine Besilate BP, indicated for treatment of mild to moderate hypertension.
• Brite Cream containing Fluocinolone Acetonide USP, Tretinoin USP and Hydroquinone USP, indicated for short-term treatment of moderate to severe melasma.
• Bteen Tablet containing Bilastine INN 20 mg, indicated for seasonal and perennial allergic rhinitis, allergic skin disorders, and chronic idiopathic urticaria.
• Ceficap Capsule and PFS containing Cefixime Trihydrate USP, indicated for MDR Typhoid fever, urinary tract infections, sinusitis, pharyngitis, and pneumonia.
• Cefokid PFS containing Cefpodoxime proxetil USP, indicated for upper and lower respiratory infections, urinary tract infections, skin infections, and MDR Typhoid fever.
• Cephracap Capsule containing Cephradine USP, indicated for respiratory tract infections, urinary tract infections, skin infections, and surgical prophylaxis.
• Cetaxone IM/IV injection containing Ceftriaxone, indicated for renal and urinary tract infections, lower respiratory tract infections, gonococcal infections, and bacterial meningitis.
• Cibact Tablet containing Ciprofloxacin Hydrochloride USP, indicated for urinary tract infections, sinusitis, lower respiratory tract infections, and infectious diarrhea.
• Clepam Tablet containing Clonazepam BP, indicated for epilepsy, anxiety disorders, panic disorder, and status epilepticus.
• Cofof Tablet and syrup containing Butamirate Citrate INN, indicated to relieve dry cough, whooping cough, and cough due to acute lower respiratory tract infections.
• Daporex Tablet containing Dapoxetine Hydrochloride INN, indicated for treatment of premature ejaculation in men.
• Dermotil Cream containing Clobetasol Propionate USP, indicated for psoriasis, recalcitrant dermatoses, lichen planus, and discoid lupus erythematosus.
• Desmin Tablet containing Desloratadine INN 5mg, indicated for relief of symptoms of allergic rhinitis and chronic idiopathic urticaria.
• Dexozole Capsule containing Dexlansoprazole INN, a Proton Pump Inhibitor used for relief of heartburn, healing of Erosive Esophagitis, and treatment of non-erosive GERD.
• Dofolin Tablet containing Doxophylline USP, used to treat asthma, COPD and bronchospasm.
• Easybak Tablet containing Baclofen BP, indicated for treatment of muscle spasm, spasticity, and tension-type headache.
• Egaba Capsule containing Pregabalin USP, indicated for management of neuropathic pain, post-herpetic neuralgia, and adjunctive therapy for partial onset seizures.
• Egul Sachet containing Psyllium (Ispaghula) Husk BP, indicated for constipation, raised cholesterol levels, hemorrhoids, irritable bowel syndrome, and blood glucose reduction.
• Egut Tablet and suspension containing Domperidone Maleate BP, indicated for stimulation of gut mobility, nausea and vomiting, and functional dyspepsia.
• Egyl Tablet and suspension containing Metronidazole BP, indicated for amoebiasis, trichomoniasis, giardiasis, bacterial vaginosis, and anaerobic infections.
• Elopram Tablet containing Escitalopram Oxalate USP, indicated for major depressive episodes, generalized anxiety disorder, OCD, and panic disorder.
• Emibe Tablet containing Ezetimibe INN, indicated for primary hypercholesterolemia and prevention of cardiovascular events in coronary heart disease patients.
• Empala 10 Tablet containing Empagliflozin INN, indicated as adjunct to diet and exercise for glycemic control in type 2 diabetes and to reduce cardiovascular death risk.
• Empala L Tablet containing Empagliflozin INN and Linagliptin INN, indicated for glycemic control in adults with type 2 diabetes mellitus.
• Endamycin Capsule containing Clindamycin Hydrochloride USP, indicated for respiratory tract infections, skin and soft tissue infections, and bone and joint infections.
• Enyl Tablet and suspension containing Paracetamol BP, indicated for fever, headache, toothache, bodyache, and pain relief.
• Enyl Extend Extended release tablet containing Paracetamol BP 665 mg, indicated for pain and fever relief.
• Enyl Plus Tablet containing Paracetamol BP and Caffeine BP, indicated for analgesic and antipyretic treatment with extra pain relief for headache and migraine.
• Eprox Tablet containing Naproxen BP, indicated for inflammatory rheumatic diseases, rheumatoid arthritis, osteoarthritis, and dysmenorrhoea.
• Esogap Tablet, capsule, and IV injection containing Esomeprazole, indicated for GERD treatment, H. pylori eradication, and Zollinger-Ellison Syndrome.
• Eteen Tablet and syrup containing Ebastine BP, indicated for allergic rhinitis and allergic skin disorders.
• Etuf 200 Tablet containing Tolfenamic Acid BP, indicated for acute migraine attacks and mild to moderate pain.
• Eucron Tablet containing Gliclazide BP, indicated for control of blood glucose in patients with non-insulin dependent diabetes mellitus.
• Euro Gel Hand Sanitizer Hand sanitizer containing Ethanol 66 ml and Isopropyl Alcohol 3.5 ml per 100 ml, indicated for pre-operative hand disinfection and skin disinfection.
• Euro Hand Sanitizer Hand sanitizer containing Isopropyl Alcohol 75 ml, Glycerin 1.45 ml, and Hydrogen Peroxide 4.167 ml per 100 ml.
• Euro Oral Saline Sachet containing Sodium Chloride, Potassium Chloride, Trisodium Citrate, and Glucose, indicated for replacement of fluid and electrolyte loss due to acute diarrhea and dehydration.
• Eurocal Tablet containing Calcium Carbonate BP, indicated for treatment or prevention of calcium depletion.
• Eurocal D Tablet containing Calcium Carbonate and Vitamin-D3, indicated for treatment of osteoporosis, rickets, osteomalacia, and calcium deficiency.
• EuroCal DX Tablet containing Calcium Carbonate and Vitamin D3, indicated for calcium and vitamin D supplementation.
• Eurolac Tablet and injection containing Ketorolac tromethamine USP, indicated for short-term management of moderately severe acute pain.
• Euronit Tablet and SR capsule containing Nitrofurantoin USP, indicated for treatment and prophylaxis of urinary tract infections.
• Europlex Tablet and syrup containing Vitamin B-complex (Thiamine, Riboflavin, Pyridoxine, Nicotinamide), indicated for nutritional supplementation in physiologically stressful conditions.
• Europlex Z Syrup containing Vitamin B-complex and Zinc Sulfate USP, indicated for treatment and prevention of B-vitamins and Zinc deficiencies.
• EuroSeas Syrup containing Multivitamin and Cod Liver Oil, indicated for growing children and for prevention of vitamin deficiency.
• Eurovit-C Tablet containing ascorbic acid BP, indicated for prevention and treatment of scurvy and vitamin C deficiency.
• Eurozolid Tablet and PFS containing Linezolid INN, indicated for treatment of nosocomial pneumonia and complicated skin infections.
• Fexofeda Tablet containing Fexofenadine Hydrochloride USP, indicated for relief of symptoms associated with seasonal allergic rhinitis and chronic idiopathic urticaria.
• Fixonac Tablet containing Aceclofenac BP, indicated for relief of pain and inflammation of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
• Flucocin Capsule and PFS containing Flucloxacillin BP, indicated for skin and soft tissue infections, respiratory tract infections, and surgical prophylaxis.
• Flumyc Capsule containing Fluconazole USP, indicated for vaginal candidiasis, tinea infections, oropharyngeal candidiasis, and onychomycosis.
• Fozifol Capsule containing carbonyl iron, folic acid, and zinc, indicated for treatment and prophylaxis of Iron, Folic Acid and Zinc deficiency especially during pregnancy.
• Fungitop Cream containing Miconazole Nitrate BP, indicated for dermatomycoses including tinea pedis, tinea corporis, and candidial infections.
• Fungitop HC Cream containing Miconazole Nitrate BP and Hydrocortisone USP, indicated for topical treatment of inflamed dermatoses where infection and inflammation coexist.
• Fusikin-HC Cream containing Fusidic Acid BP and Hydrocortisone Acetate BP, indicated for primary irritant dermatitis, contact allergic dermatitis, and eczema.
• Gap Capsule and IV injection containing Omeprazole BP, indicated for treatment of heartburn, GERD, erosive esophagitis, duodenal ulcer, and gastric ulcers.
• Gavifil Suspension, tablet, and sachet containing Sodium Alginate USP, Sodium Bicarbonate USP, and Calcium Carbonate BP, indicated for acid related symptoms of GERD.
• Geloxin Tablet containing Gemifloxacin Mesylate INN, indicated for acute bacterial exacerbation of chronic bronchitis and community-acquired pneumonia.
• KetoDruff Shampoo containing Ketoconazole BP, indicated for treatment and prophylaxis of dandruff and seborrheic dermatitis.
• KetoKid Tablet and syrup containing Ketotifen Fumarate BP, indicated for prophylactic treatment of bronchial asthma and allergic conditions.
• KofCure Syrup containing Dextromethorphan Hydrobromide BP, Pseudoephedrine Hydrochloride BP, and Triprolidine Hydrochloride BP, indicated for symptomatic relief of upper respiratory tract disorders with non-productive cough.
• Lactulose Oral solution indicated for chronic constipation, intestinal flora disturbances, and increased blood ammonia levels.
• LetroCare Tablet containing Letrozole USP, indicated for adjuvant treatment of hormone receptor positive early breast cancer in postmenopausal women.
• Levotiz Tablet containing Levocetirizine Dihydrochloride INN, indicated for treatment of symptoms associated with allergic conditions.
• Lezon Tablet containing Levofloxacin Hemihydrate INN, indicated for treatment of respiratory tract infections, urinary tract infections, and skin infections.
• Ligend Tablet containing Linagliptin INN 5 mg, indicated for Type 2 Diabetes Mellitus.
• Ligend-M Tablet containing Linagliptin INN and Metformin Hydrochloride BP, indicated for glycemic control in type 2 diabetes mellitus.
• Mebevin 135 Tablet containing Mebeverine HCl BP, indicated for symptomatic treatment of irritable bowel syndrome and chronic irritable colon.
• Misotab Tablet containing Misoprostol BP, indicated for reducing risk of NSAID-induced gastric ulcers and for labor induction and postpartum hemorrhage prevention.
• Mitazapine Tablet containing Mirtazapine USP, indicated for treatment of major depression disorder, depression with anxiety, and depression with insomnia.
• Montica Chewable tablet containing Montelukast Sodium INN, indicated for prophylaxis and chronic treatment of asthma.
• Moxier Tablet containing Moxifloxacin Hydrochloride USP, indicated for acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and community acquired pneumonia.
• MR Kit Kit containing Mifepristone INN 200 mg and Misoprostol BP 200 mcg, indicated for termination of pregnancy up to 9 weeks of gestation.
• Mupiskin Ointment containing Mupirocin USP, indicated for topical treatment of impetigo due to Staphylococcus aureus and Streptococcus pyogenes.
• Napreso Enteric coated tablet containing Naproxen BP and Esomeprazole Magnesium Trihydrate USP, indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.
• Nenvit Tablet containing Thiamine Mononitrate BP, Pyridoxine Hydrochloride BP, and Cyanocobalamin BP, indicated in low back pain and polyneuropathy.
• Nixamid Tablet containing Nitazoxanide INN 500 mg, indicated for diarrhoea caused by Cryptosporidium parvum and Giardia lamblia, amebiasis and helminth infections.
• NoFat 120 Capsule containing Orlistat USP, indicated in conjunction with diet for treatment of obese patients with BMI greater than 30 kg/m2.
• Obemet Film coated tablet containing Metformin Hydrochloride BP, indicated for non-insulin dependent adult diabetes mellitus.
• Opalgic Capsule containing Tramadol Hydrochloride BP, used for treatment of moderate to severe painful conditions including postoperative pain and cancer pain.
• Oropem IV injection containing Meropenem USP, indicated for pneumonia, urinary tract infections, intra-abdominal infections, and meningitis.
• Osedan Tablet containing Ondansetron Hydrochloride Dihydrate BP, indicated for prevention of nausea and vomiting associated with chemotherapy and radiotherapy.
• Painliv Cream containing Methyl Salicylate BP, Menthol USP, and Camphor BP, indicated for fast relief of minor aches and pains of muscles and joints.
• Paratadol Tablet containing Paracetamol BP and Tramadol hydrochloride BP, indicated for management of moderate to moderately severe pain.
• Parnil DS Chewable tablet containing Albendazole USP 400 mg, indicated for treatment of parasite infestations including pinworm, whipworm, hookworm, and roundworm.
• Penticin Tablet containing Flupenthixol INN and Melitracen INN, indicated in anxiety along with depression and apathy.
• Protozin Enteric coated tablet containing Pantoprazole Sodium Sesquihydrate BP, indicated for duodenal ulcer, gastric ulcer, and Zollinger-Ellison syndrome.
• Rabepra Enteric coated tablet containing Rabeprazole Sodium INN, indicated for healing of erosive GERD, duodenal ulcers, and H. pylori eradication.
• Renete Tablet containing Ranitidine Hydrochloride BP, indicated for treatment of duodenal ulcer, benign gastric ulcer, and reflux esophagitis.
• Roxiclav Tablet containing Cefuroxime Axetil USP and Clavulanic Acid, indicated for respiratory tract infections, urinary tract infections, and skin infections.
• Rupita Tablet containing Rupatadine Fumarate INN, indicated for seasonal and perennial allergic rhinitis and chronic idiopathic urticaria.
• Sitaglap Tablet containing Sitagliptin Phosphate Monohydrate USP, indicated as adjunct to diet and exercise for glycemic control in type 2 diabetes mellitus.
• Sitaglap M Tablet containing Sitagliptin Phosphate Monohydrate USP and Metformin Hydrochloride BP, indicated for glycemic control in adults with type 2 diabetes.
• Spazin Tablet containing Tiemonium Methylsulphate INN, indicated for pain in gastrointestinal, biliary, urinary and gynaecological disease.
• Sucralose Sachet containing Sucralose, a sugar substitute suitable for diabetic patients and health-conscious people.
• Terbosis Cream containing Terbinafine HCl, indicated for fungal infections of the skin caused by Trichophyton and yeast infections.
• Texamic Capsule containing Tranexamic Acid BP, indicated for haemorrhage and hereditary angioedema.
• Tiz Tablet and syrup containing Cetirizine Hydrochloride BP, indicated for relief of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis.
• Tolride Tablet containing Tolperisone Hydrochloride INN, indicated for painful muscle spasm and muscle spasticity associated with neurological conditions.
• TopUp Tablet containing Tadalafil, indicated for treatment of erectile dysfunction and signs of benign prostatic hyperplasia.
• Torbi Tablet containing Etoricoxib INN, indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, and acute gout.
• Tulsi Syrup containing Carbocisteine BP, indicated for chronic obstructive pulmonary disease, bronchitis, and bronchial asthma.
• Uropine Tablet containing Quetiapine Fumarate USP, indicated for treatment of acute manic episodes associated with bipolar disorder and schizophrenia.
• Uroxime Tablet and PFS containing Cefuroxime Axetil USP, indicated for upper and lower respiratory tract infections, urinary tract infections, and gonorrhoea.
• Varnafil Tablet containing Vardenafil Hydrochloride Trihydrate BP, indicated for erectile dysfunction.
• Vegara Tablet containing Sildenafil Citrate INN, indicated for treatment of erectile dysfunction.
• Vita AZ Gold Comprehensive multivitamin and multimineral preparation with 32 ingredients, indicated for prevention and treatment of vitamins and minerals deficiencies.
• Vita AZ Silver Formulation comprising important vitamins and minerals, indicated for prevention and treatment of vitamin and mineral deficiencies for adults over 50 years.
• Vita-D Tablet and capsule containing Colecalciferol BP (Vitamin D3), indicated for treatment and prevention of Vitamin D3 deficiency.
• VitaCoral-DX Tablet containing Coral Calcium Carbonate and Vitamin D3, indicated for treatment and prevention of osteoporosis, osteomalacia, and calcium deficiency.
• Vonotop Tablet containing Vonoprazan Fumarate INN, indicated for gastric ulcer, duodenal ulcer, reflux esophagitis, and as adjunct to H. pylori eradication.
• Vorile Capsule and PFS containing Voriconazole USP, indicated for invasive aspergillosis, candidemia, and esophageal candidiasis.
• Xiopam Tablet containing Bromazepam BP, indicated for treatment of anxiety and anxiety related disorders.
• Zemin Syrup containing Zinc Sulphate Monohydrate USP, indicated for zinc deficiency conditions including recurrent respiratory tract infections and impaired wound healing.
• Zemin DS Syrup containing Zinc Sulphate Monohydrate USP equivalent to 20 mg elemental Zinc, indicated for zinc deficiency conditions with higher dosage.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Eskayef Pharmaceuticals (SK+F): Bangladeshi generics manufacturer producing a wide range of oral solids, injectables and topicals across the same therapeutic categories. Comparable in product format diversity and domestic Bangladesh market focus.
• Incepta Pharmaceuticals: Bangladesh-based manufacturer producing a wide generic drug portfolio across tablets, capsules, injectables, and topicals. Closely comparable in scale, product breadth, dosage forms, and Bangladesh-only commercial focus.
• Beximco Pharmaceuticals: Leading Bangladeshi generics manufacturer with export operations in 50+ countries and the same broad therapeutic-category coverage. Comparable as a Bangladesh-based generics competitor pursuing both domestic share and international expansion.
• Square Pharmaceuticals: Bangladesh's largest pharmaceutical manufacturer with a broad generics portfolio spanning the same therapeutic categories (cardiovascular, antibiotics, antidiabetics) and nationwide distribution. Most directly comparable peer given overlap in product mix, dosage forms, and Bangladesh market focus.
• Renata Limited: Major Bangladeshi pharma company with a broad animal-health and human-health generics portfolio, including cardiovascular and endocrine products. Comparable in Bangladesh-only operations and therapeutic-area overlap with EURO Pharma.
• Drug International Limited: Bangladesh-based pharmaceutical company manufacturing generics in tablets, capsules, injectables, and topicals across multiple therapeutic areas. Comparable mid-sized Bangladesh peer in product breadth and dosage-form diversity.
• Healthcare Pharmaceuticals: Bangladesh-based generics manufacturer with a portfolio covering similar therapeutic classes (cardiology, respiratory, GI) and domestic-market orientation. Closely comparable mid-sized Bangladesh pharma peer.
• ACI Limited (Pharma Division): Diversified Bangladeshi conglomerate with a significant pharmaceutical manufacturing arm producing generics across cardiovascular, antibiotic and antidiabetic categories. Comparable in Bangladesh market focus and broad therapeutic coverage.
• Aristopharma Limited: Bangladesh pharmaceutical manufacturer producing generics across antibiotics, cardiovascular, dermatology, and respiratory categories. Comparable as a domestic-focused Bangladesh generics competitor with similar product mix.

Regional players

• Beacon Pharmaceuticals: Bangladesh oncology and specialty-focused pharmaceutical manufacturer with broader generics coverage. Comparable in Bangladesh market focus, though Beacon is more concentrated in oncology/specialty injectables than EURO Pharma's horizontal generics portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/euro-pharma-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EURO Pharma Ltd.